[Use of anti-VEGF (anti-vascular endothelial growth factor) in Retinopathy of Prematurity (ROP)]

Arch Soc Esp Oftalmol. 2011 Jul;86(7):207-8. doi: 10.1016/j.oftal.2011.05.008. Epub 2011 Jul 5.
[Article in Spanish]
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Cryotherapy
  • Humans
  • Infant, Newborn
  • Laser Therapy
  • Retinopathy of Prematurity / drug therapy*
  • Retinopathy of Prematurity / physiopathology
  • Retinopathy of Prematurity / surgery
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab